These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 3973424)
21. IgG subclass response and opsonization of Streptococcus pneumoniae after vaccination of healthy adults. Bardardottir E; Jonsson S; Jonsdottir I; Sigfusson A; Valdimarsson H J Infect Dis; 1990 Aug; 162(2):482-8. PubMed ID: 2373875 [TBL] [Abstract][Full Text] [Related]
22. Specific immunoglobulin-class antibody responses in the elderly before and after 14-valent pneumococcal vaccine. Ruben FL; Uhrin M J Infect Dis; 1985 May; 151(5):845-9. PubMed ID: 3989318 [TBL] [Abstract][Full Text] [Related]
23. Antibody response to pneumococcal polysaccharides in insulin-dependent diabetes mellitus. Lederman MM; Rodman HM; Schacter BZ; Jones PK; Schiffman G Diabetes Care; 1982; 5(1):36-9. PubMed ID: 6754301 [TBL] [Abstract][Full Text] [Related]
24. Pneumococcal polysaccharides induce antibody formation by human B lymphocytes in vitro. Rijkers GT; Mosier DE J Immunol; 1985 Jul; 135(1):1-4. PubMed ID: 3889152 [No Abstract] [Full Text] [Related]
25. Planning for a second (23 valent) generation pneumococcal vaccine. With special reference to new developments in our understanding of the structure and biology of polysaccharides. Robbins JB; Schneerson R Bull Eur Physiopathol Respir; 1983; 19(2):215-26. PubMed ID: 6347282 [TBL] [Abstract][Full Text] [Related]
26. Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers. Szu SC; Lee CJ; Parke JC; Schiffman G; Henrichsen J; Austrian R; Rastogi SC; Robbins JB Infect Immun; 1982 Mar; 35(3):777-82. PubMed ID: 7068216 [TBL] [Abstract][Full Text] [Related]
27. Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics. Beam TR; Crigler ED; Goldman JK; Schiffman G JAMA; 1980 Dec; 244(23):2621-4. PubMed ID: 7431608 [TBL] [Abstract][Full Text] [Related]
35. Impaired antibody responses to a pneumococcal polysaccharide vaccine in patients with non-Hodgkin's lymphoma in remission. Ballester OF; Shurafa M; Toben H; Kumar KS; Burek CL J Clin Immunol; 1981 Apr; 1(2):90-3. PubMed ID: 7334071 [TBL] [Abstract][Full Text] [Related]
36. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines. Austrian R J Infect Dis; 1977 Aug; 136 Suppl():S38-42. PubMed ID: 19543 [TBL] [Abstract][Full Text] [Related]
37. Immunogenetic analysis of the immune response to pneumococcal polysaccharide. Baxendale HE; Davis Z; White HN; Spellerberg MB; Stevenson FK; Goldblatt D Eur J Immunol; 2000 Apr; 30(4):1214-23. PubMed ID: 10760811 [TBL] [Abstract][Full Text] [Related]